Implementing genome-driven oncology Journal Article


Authors: Hyman, D. M.; Taylor, B. S.; Baselga, J.
Article Title: Implementing genome-driven oncology
Abstract: Early successes in identifying and targeting individual oncogenic drivers, together with the increasing feasibility of sequencing tumor genomes, have brought forth the promise of genome-driven oncology care. As we expand the breadth and depth of genomic analyses, the biological and clinical complexity of its implementation will be unparalleled. Challenges include target credentialing and validation, implementing drug combinations, clinical trial designs, targeting tumor heterogeneity, and deploying technologies beyond DNA sequencing, among others. We review how contemporary approaches are tackling these challenges and will ultimately serve as an engine for biological discovery and increase our insight into cancer and its treatment. © 2017
Keywords: targeted therapy; next-generation sequencing; precision medicine; basket studies; genome-driven oncology
Journal Title: Cell
Volume: 168
Issue: 4
ISSN: 0092-8674
Publisher: Cell Press  
Date Published: 2017-02-09
Start Page: 584
End Page: 599
Language: English
DOI: 10.1016/j.cell.2016.12.015
PROVIDER: scopus
PUBMED: 28187282
PMCID: PMC5463457
DOI/URL:
Notes: Review -- Export Date: 2 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Hyman
    354 Hyman
  2. Barry Stephen Taylor
    238 Taylor
  3. Jose T Baselga
    484 Baselga